PREPARATION OF GMP REPORT

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Radiopharmaceutical Production
Radiopharmaceutical Production
Annual Product Review (APR) Product Quality Review (PQR)
Regulatory Challenges in the Cell Preparation Facility Adrian Gee Center for Cell & Gene Therapy Regulatory Challenges in the Cell Preparation Facility.
GMP Document and Record Retention
World Health Organization
Quality control of raw materials In-process control
World Health Organization
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Radiopharmaceutical Production
World Health Organization
Basic Principles of GMP
ASEAN GMP TRAINING MODULE PERSONNEL
© 2011 Michigan State University and United Nations Industrial Development Organization, original at CC-BY-SA Procedures FSKN.
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.
Module 20 | Slide 1 of 35 January 2006 GMP Inspection Process The Inspection.
Railway Transport Equipment (RTE) Certification Railway Transport Equipment Certification Procedure Application for railway transport equipment certification.
Important informations
ISO / IEC : 2012 Conformity assessment – Requirements for the operation of various types of bodies performing inspection.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
Basic Principles of GMP
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Validation | Slide 1 of 27 August 2006 Validation Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series, No. 937, 2006.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
Chapter 10 Employee Retention and Terminations.
TOTAL QUALITY MANAGEMENT
International conference Quality of Active Pharmaceutical Ingredients Hyderabad, September 2009 API Inspections: the EDQM experience – 7 September.
Module 14Slide 1 of 23 WHO - EDM Basic Principles of GMP Active Pharmaceutical Ingredients Part Three, 18.
Quality Control significance in pharmaceutical industry
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
Responsibilities of Test Facility Management, Study Director, Principal Investigator and Study Personnel G. Jacobs Belgian GLP Monitorate Zagreb, 17 December.
Responsibilities of Sponsor, Investigator and Monitor
LABORATORY SAMPLES AND CONTRACT MANAGEMENT
World Health Organization
National Food Control Systems
BSB Biomanufacturing CHAPTER 4 GMP – Documentation Part I (SOP)
Author: Nurul Azyyati Sabri
GD211 Training Module 5 Conclusions.
World Health Organization
Responsibilities of Sponsor, Investigator and Monitor
ISO/IEC
Tender Evaluation and Award Process
World Health Organization
Administration of a FIDIC Contract - Project Control
CONDUCTING OF GMP INSPECTION
CLASSIFICATION OF GMP NON-CONFORMANCE
PREPARATION FOR GMP INSPECTION
PHARMACEUTICAL QUALITY
ExTAG Training Workshop Calgary 2012 QAR related Issues
Flooding Walkdown Guidance
Food Production Systems
GMP Inspection Process
GMP Inspection Process
Prerequisite Programs
GMP Inspection Process
GMP Inspection Process
Management Verifications & Sampling Methods
World Health Organization
How to conduct Effective Stage-1 Audit
Overview: ICS Evaluation Procedures
EU Food Safety Requirements: - Hygiene of Foodstuffs -
ESS approach and support for Declaration of Conformity (CE-marking) Fredrik Håkansson ESS Accelerator Collaboration Board Meeting Trieste
Computer System Validation
Radiopharmaceutical Production
Radiopharmaceutical Production
Radiopharmaceutical Production
Nonconformity Writing
Permit to Work Process​ HSE GROUP RULE (CR-GR-HSE-402)
Panel discussion GMP inspection process – Health Canada
Presentation transcript:

PREPARATION OF GMP REPORT Malaysia & Indonesia

To review the activities after GMP inspection. OBJECTIVE To review the activities after GMP inspection. The objectives of this module are to review the activities that need to be carried out when you are preparing for an inspection. We will look at the key issues relating to the preparation for an inspection and review the particular issues that relate to inspections in your country. 2

POST-INSPECTION Definition of deficiencies Inspection report format Inspection report details Inspection report distribution Follow–up action

DEFICIENCIES All deficiencies found should be listed, even if corrective action has taken place straight away. If the deficiencies are related to the assessment of the marketing application, this should be clearly stated. 4

DEFICIENCIES Deficiencies classification: Critical Major Minor 5

EXAMPLES CLASSIFICATION EXAMPLE OF DEFICIENCIES: Critical The design of the manufacturing premises did not meet the basic GMP requirement. Examples: No changing room and buffer room for raw material and packaging material provided. Storage of raw material was inside the production area. Major There were a number of important documents which have yet to be established by the company. Example; Procedures for handling the receipt of raw materials. Maintenance procedures for water systems dehydrated ion (DI Water) Records of cleaning activities in the area of production. Stocks cards for raw materials and packaging materials stored in the storage area. Minor Procedures for handling medical examinations were provided. However, no information on the frequency of health checks specified in the mention procedures . FOR FORTHER INFORMATION: REFER TO CLASSIFICATION OF GMP NON-CONFORMANCE TRAINING MODULE 6

INSPECTION REPORT FORMAT Inspection Report content: General information on company. First part, General information about the company can be taken directly from the information provided by the company itself, provided it is annotated as such and verified during the inspection. The second part should describe the progress of the inspection, listing all the parts of the factory, warehouse, laboratory etc that have been inspected. The third part is devoted to observations, either negative or positive, including any major changes (improvements and deterioration) that have taken place since the previous visit. Negative observations should differentiate between poor systems and failure to comply with the system. An example is lack of cleaning in a particular area. Is it due to an inadequate SOP, or lack of compliance with an SOP that covers all aspects of cleaning. Positive observations should be recorded A description of the process that is carried out particularly well and would be considered as examples of good manufacturing practice. The final part consists of the inspectors’ summary and conclusion, including corrective actions and recommendations. You could also add any supplementary documentation as annexes to the report.

INSPECTION REPORT FORMAT Inspection Report content: Description of the inspection. Observations.

INSPECTION REPORT FORMAT Inspection Report content: Conclusion and recommendation. Annexes-Attendance List. Inspector(s) signature.

REPORT WRITING All inspections conducted should be reported using a standard format. Report should be written by inspector(s) involved. Compiled by the Lead Inspector. Keep it simple and based on fact. The conclusion of the GMP Inspection should be stated at the end of the report followed by a disclaimer and signed by the inspector(s). The whole inspectorate should have a consistent style for inspection reports that is used by everyone (using a standard format). Here are a few suggestions on making the report readable and effective: Use the past tense: “It was observed...” or “It was noted that...” Keep it simple and based on fact - it is not necessary to complicate the report. There is no room for opinion or ambiguities - remember the specifics that we discussed earlier when referring to documents, products or equipment. There are some aspects that should not be included in the report, although they may be discussed at the exit meeting if appropriate: Your subjective opinions as opposed to fact. Information that is not relevant to the inspection. Ambiguous statements that cannot be supported. Antagonistic statements that do not contribute to the inspection.

REPORT WRITING Do not include: Subjective opinions Irrelevant information Ambiguous statements Antagonist statements The whole inspectorate should have a consistent style for inspection reports that is used by everyone (using a standard format). Here are a few suggestions on making the report readable and effective: Use the past tense: “It was observed...” or “It was noted that...” Keep it simple and based on fact - it is not necessary to complicate the report. There is no room for opinion or ambiguities - remember the specifics that we discussed earlier when referring to documents, products or equipment. There are some aspects that should not be included in the report, although they may be discussed at the exit meeting if appropriate: Your subjective opinions as opposed to fact. Information that is not relevant to the inspection. Ambiguous statements that cannot be supported. Antagonistic statements that do not contribute to the inspection.

REPORT WRITING When reporting non-compliances the following aspect should be considered: It must be possible to identify exactly where the non-compliance was and, therefore, the location, piece of equipment, document or job title of individual referred to must be identified. The non-compliance should be described according to the relevant PIC/S chapters or any GMP guideline that was made for reference at the time of inspection.

Inspection reports are treated as confidential documents. GMP INSPECTION REPORT REPORT WRITING REMEMBER!!! Inspection reports are treated as confidential documents. Inspection reports are normally treated as confidential documents, depending on national legislation. However, under certain international agreements, reports are exchanged between regulatory authorities (e.g. mutual recognition agreements, memoranda of understanding or signatories to co-operation schemes).

REPORT DISTRIBUTION The inspection report: Sent out to the company. Company must reply to the inspection report within 30 days unless there is acceptable reason. After the report has obtained supervisory approval, it should be sent with a covering letter to the company management. 14

FOLLOW UP The Head of GMP Compliance will received the company’s response letter and forward it to the inspector for review.

FOLLOW UP Deficiencies may be considered as resolved if the response letter: States that corrective and preventative measures have been implemented, and includes supporting documentation, if necessary. Provides a written commitment, providing a clear and reasonable schedule for implementation of corrective and preventative measures.

FOLLOW UP If the corrective and preventative measures taken by the company are not considered to be acceptable, further correspondence may be necessary.

World Health Organization 23 June, 2018 PUNITIVE ACTION Unacceptable GMP Compliance Compliance related communications which alert the manufacturer to the regulatory authority’s concern, and possibility for future regulatory action if remedial action is not effective Regulatory action against the site authorisation or GMP approval (refusal, suspension or amendment of an establishment licence) Market action such as recall (voluntary or mandated by regulatory authority) Prohibition of supply/ importation Prosecution Communications to the public using public warning/ public advisory or information updates; Suspension or cancellation of Marketing Authorisation/Product Licence Health product label or changes The inspectorate of a regulatory authority normally has certain powers to allow for regulatory actions. The regulatory actions are based on and controlled by national legislation The purpose of the regulatory action is to ensure that unsatisfactory situations in manufacturing sites are corrected in the interest of the public by ensuring that safe, effective, quality pharmaceutical products are manufactured. These powers or regulatory actions often include: - Closure of a facility (only used in an extreme case where a health hazard is perceived) - Suspension or revoking of the marketing authorisation. - Delay in approval of licenses or marketing authorisations. - Delay in issue of a GMP certificate. - Initiation of a product recall.

REFERENCES PIC/S INSPECTION REPORT FORMAT; PI013-3; 2007 NPRA PROCEDURE FOR PREPARING A GMP INSPECTION REPORT : PKP/200/309